title: Systemic human antisense therapy begins.
authors.forename: E
authors.initials: E
authors.lastname: Bayever
authors.forename: P
authors.initials: P
authors.lastname: Iversen
authors.forename: L
authors.initials: L
authors.lastname: Smith
authors.forename: J
authors.initials: J
authors.lastname: Spinolo
authors.forename: G
authors.initials: G
authors.lastname: Zon
mesh_terms: D000328:Adult; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D016158:Genes, p53; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use* / Q000633:toxicity; D014407:Tumor Cells, Cultured
chemical_list: D016376:Oligonucleotides, Antisense